All news

Cardinal Health extends CVS deal. What it means for Cardinal Health stock

Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash

Cardinal Health has extended its pharmaceutical distribution agreement with CVS Health through June 30, 2032. The company also reaffirmed its fiscal year 2027 non-GAAP earnings per share guidance, projecting 13% to 15% growth. The Cardinal Health stock traded flat at EUR 202.90 in weekend trading after the announcement.

Read original source

CAH company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.